from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv2546/vapC18

LFCtreatmentdescriptionclass of inhibitor

0.456

Amikacinug/mL Amikacintranslation

-0.235

Cap5-10ug/mL Capreomycintranslation

-0.324

Rox10-50 ug/mL Roxithromycintranslation

-0.303

SM2-5 ug/mL Streptomycintranslation

0.148

Tet5-10 ug/mL Tetracyclinetranslation

2.264

Rif0.2-5ug/mL Rifampicintranscription

0.267

Rifp0.1-0.5ug/mL Rifapentinetranscription

-0.317

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

1.131

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

0.413

CPZ10-50 ug/mL Chlorpromazinerespiration

-1.036

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.393

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-0.161

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

1.479

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

0.811

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.752

Econazole10-24 ug/mL Econazole (azole drug)respiration

-2.438

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-0.135

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-0.339

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.477

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-1.235

KCN5-20 ug/mL Potassium cyaniderespiration

0.000

NaN30.2-2 mM Sodium aziderespiration

-0.540

Nigericin50 uM Nigericinrespiration

0.667

TRC10-150 ug/mL Triclosanrespiration

-0.186

TRZ10-25 ug/mL Thioridazinerespiration

-0.282

Valinomycin0.5-10 uM Valinomycinrespiration

0.000

ZnSO42 mM ZnSO4respiration

-0.991

menadione6-10 ug/mL Menadionerespiration

0.188

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.527

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.240

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-1.370

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-0.824

NRP_1Non-replicating persistence stage 1dosRassociated

-0.511

Amp0.2mg/mL AmpicillincellWall

-0.397

Cephalexin20-100 ug/mL CephalexincellWall

-0.516

Cerulenin0.32-5 ug/mL CerulenincellWall

0.491

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.720

EMB10-20 ug/mL EthambutolcellWall

-0.256

Eta12-40 ug/mL EthionamidecellWall

-0.726

INH0.2-0.4 ug/mL IsoniazidcellWall

0.513

TLM0.1-0.2 mg/mL ThiolactomycincellWall

0.145

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-1.021

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.553

BZA0.12 mg/mL BenzamidearomaticAmides

0.556

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.140

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.255

H2O24 mM hydrogen peroxideDNAdamaging

-0.204

Levo10 ug/mL LevofloxacinDNAdamaging

-0.461

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-0.476

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.112

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.967

UVUV-irradiationDNAdamaging

1.351

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.945

Antimycin12.5-50 ug/mL Antimycin A?

-0.896

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.041

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.016

PA_2110-50 ug/mL Antitubercular compound PA-21?

-0.465

PA8240.2-2 ug/mL PA-824?

0.510

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.229

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.330

Verapamil50 uM Verapamil?

0.706

mercaptoethanol2 mM 2-Mercaptoethanol?

-1.319

methoxatin10-20 ug/mL Methoxatin?